Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children11The Amplatzer VSD occluders were provided by AGA, Medical Corporation, Golden Valley, Minnesota. There were no sources of financial support.
- 1 April 1999
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 33 (5) , 1395-1399
- https://doi.org/10.1016/s0735-1097(99)00011-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Closure of Atrial Septal Defects With the Amplatzer Occlusion Device: Preliminary ResultsJournal of the American College of Cardiology, 1998
- Closure of Muscular Ventricular Septal Defects With Modified Amplatz Device in a Canine ModelJournal of the American College of Cardiology, 1998
- Transvenous Closure of Secundum Atrial Septal DefectsCirculation, 1997
- Apical Muscular Ventricular Septal Defects Between the Left Ventricle and the Right Ventricular InfundibulumCirculation, 1997
- Occlusion of congenital ventricular septal defects by the buttoned device. "Buttoned device" Clinical Trials International Register.Heart, 1997
- Transesophageal echocardiographic guidance of transcatheter ventricular septal defect closureJournal of the American College of Cardiology, 1994
- Preoperative Transcatheter Closure of Congenital Muscular Ventricular Septal DefectsNew England Journal of Medicine, 1991
- Transcatheter closure of ventricular septal defects.Circulation, 1988